Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1822]

Venetoclax chemo combo active and well-tolerated in children with r/r AML

Dr Seth Karol - St. Jude Children’s Research Hospital, Memphis, USA

Venetoclax chemo combo active and well-tolerated in children with r/r AML ( Dr Seth Karol - St. Jude Children’s Research Hospital, Memphis, USA )

Laser therapy for vulvo-vaginal atrophy / genito-urinary syndrome of menopause...

Prof Deborah Fenlon - Swansea University, Swansea, UK

Laser therapy for vulvo-vaginal atrophy / genito-urinary syndrome of menopause in breast cancer survivors ( Prof Deborah Fenlon - Swansea University, Swansea, UK )

Depth of response to daratumumab, lenalidomide, bortezomib, and dexamethasone...

Prof Peter Voorhees - Levine Cancer Institute, Charlotte, USA

Depth of response to daratumumab, lenalidomide, bortezomib, and dexamethasone improves over time in transplant-eligible newly diagnosed multiple myeloma ( Prof Peter Voorhees - Levine Cancer Institute, Charlotte, USA )

Blinatumomab vs chemotherapy as post-reinduction therapy in HR/IR first relapse...

Dr Patrick Brown - Johns Hopkins University, Baltimore, USA

Blinatumomab vs chemotherapy as post-reinduction therapy in HR/IR first relapse of B-ALL in children and adolescents ( Dr Patrick Brown - Johns Hopkins University, Baltimore, USA )

Maintenance therapy with CC-486 for acute myeloid leukaemia

Prof Andrew Wei - Monash University, Melbourne, Australia

Maintenance therapy with CC-486 for acute myeloid leukaemia ( Prof Andrew Wei - Monash University, Melbourne, Australia )

Daratumuab, carfilzomib and dexamethasone increases survival in patients with...

Dr Saad Usmani - Levine Cancer Institute, Charlotte, USA

$Daratumuab, carfilzomib and dexamethasone increases survival in patients with relapsed/refractory multiple myeloma ( Dr Saad Usmani - Levine Cancer Institute, Charlotte, USA )$

QUAZAR AML-001: Evaluating CC-486 as a maintenance therapy for older patients...

Prof Andrew Wei - Monash University, Melbourne, Australia

QUAZAR AML-001: Evaluating CC-486 as a maintenance therapy for older patients with acute myeloid leukaemia in first remission ( Prof Andrew Wei - Monash University, Melbourne, Australia )

Blinatumomab demonstrates superior efficacy compared to chemotherapy in...

Dr Patrick Brown - Johns Hopkins University, Baltimore, USA

Blinatumomab demonstrates superior efficacy compared to chemotherapy in children and young adults with relapsed B-ALL ( Dr Patrick Brown - Johns Hopkins University, Baltimore, USA )

Maintenance decitabine after intensive therapy for AML in older FLT3-ITD...

Dr James Foran - Mayo Clinic Florida, Jacksonville, USA

Maintenance decitabine after intensive therapy for AML in older FLT3-ITD-negative patients ( Dr James Foran - Mayo Clinic Florida, Jacksonville, USA )

Polypharmacy and medication management in geriatric oncology

Dr Ginah Nightingale - Thomas Jefferson University, Philadelphia, USA

Polypharmacy and medication management in geriatric oncology ( Dr Ginah Nightingale - Thomas Jefferson University, Philadelphia, USA )

Immunotherapy and targeted agents for elderly lung cancer patients

Dr Lore Decoster - University Hospital Brussels, Brussels, Belgium

Immunotherapy and targeted agents for elderly lung cancer patients ( Dr Lore Decoster - University Hospital Brussels, Brussels, Belgium )

The use of radiation therapy in older adults

Dr Noam VanderWalde - University of Tennessee West Cancer Center., Memphis, USA

The use of radiation therapy in older adults ( Dr Noam VanderWalde - University of Tennessee West Cancer Center., Memphis, USA )

More from ecancer